General Announcement: Winner of Queen’s Award for Enterprise 2020 (Innovation). Rayner RayOne Fully Preloaded IOL Injection System for Treating Cataracts

Posted on 21/04/2020

Worthing (UK) – Rayner, the manufacturer of the world’s first Intraocular Lens (IOL), has been recognised for its excellence in innovation by winning the esteemed and internationally recognised Queen’s Award for Enterprise (QAE) for its RayOne fully preloaded IOL injection system, designed to create the smallest fully preloaded IOL incision during cataract surgery. Now in

Read more

COVID-19 Rayner Announcement

Posted on 20/03/2020

Dear All, I want to reassure you in these uncertain times. Rayner is very fortunate to operate globally and in an industry which is critical. Despite the worsening situation in Europe and the Americas we are thankfully seeing improvements in Asia. Several large markets are operating relatively unaffected. Despite the turmoil that we see on

Read more

Rayner launching RayOne Trifocal Toric at ESCRS to complete its trifocal IOL family

Posted on 11/09/2019

Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

Read more

Rayner partners and acquires stake in Reper to drive R&D and build presence in Russia.

Posted on 1/09/2019

Rayner partners and acquires stake in Reper to drive R&D and build presence in Russia. Following a four-year R&D collaboration on a novel hydrophobic IOL material, Rayner has acquired a substantial stake in Reper, a leading material science and medical device company based in Russia. The new proprietary non-glistening material is the basis for RayOne

Read more

US surgeons to access the smallest fully preloaded IOL incision. RayOne Aspheric receives FDA clearance.

Posted on 11/12/2018

Rayner set to launch 600C monofocal aspheric IOL at ASCRS

Rayner has announced the launch of the 600C Aspheric IOL. The 600C Aspheric IOL will be unveiled at the upcoming 2018 ASCRS conference in Washington, DC, 13-17 A...

Read more

Open Brexit letter from Rayner CEO

Posted on 4/09/2018

In response from the letter received from the RtHon Matt Hancock MP, Secretary of State for Health:

Rayner is a UK headquartered business and the only manufacturer of intraocular lenses (IOLs) in the UK, pr...

Read more

The world’s first Trifocal Supplementary IOL. Rayner set to launch the Sulcoflex Trifocal at the 2018 ESCRS in Vienna.

Posted on 7/08/2018

Rayner are proud to announce the launch of the new, CE marked Sulcoflex Trifocal Pseudophakic Supplementary IOL at the 2018 ESCRS in Vienna

...

Read more

Rayner: Leading the way to offer more patients a trifocal solution. Surgeon panel discussion on RayOne Trifocal and the new Sulcoflex Trifocal.

Posted on 3/07/2018

A Satellite Symposium Sponsored by Rayner at the 2018 ESCRS on Sunday 23rd September at 1pm.

Professor Oliver Findl, Dr Tiago Ferreira, Professor Michael Amon, Dr Alessandro Mularoni, Dr Fernando Llovet-Osu...

Read more

Supporting paediatric cataract surgery in Ethiopia

Posted on 21/06/2018

Rayner is proud to have supplied Dr Woodruff with Rayner C-flex Aspheric Monofocal IOLs and OphteisBio 3% OVD for his recent visit to Ethiopia as Visiting Professor & Mentor in Paediatric Ophthalmology, Gondar University Hospital 25th March...

Read more

Rayner receives CE Mark for its high performance hydrophobic fully preloaded IOL injection system

Posted on 14/05/2018

RayOne Hydrophobic, Rayner’s first fully preloaded IOL system with a hydrophobic acrylic lens, is now available to CE Mark-accepting countries. Daily compromises faced by cataract surgeons are eliminated with a new proprietary material, unique Cornerstone lens shape and intuitive fully preloaded injector. Worthing (UK), May 22nd, 2018 – Rayner, the manufacturer of the world’s first IOL,

Read more